ADHD Throughout the Lifespan

All sessions will be held in Pacific Time (PT).

Saturday, August 26, 2023

7:00 am - 8:00 am

Back When I Was Young: Managing Pediatric ADHD

Adelaide S. Robb, MD

Selecting the optimal ADHD medication for children and adolescents can be challenging. Clinicians must balance efficacy, tolerability, and the strategy that best suits the individual needs of the patient. In this presentation, Dr. Adelaide Robb will provide guidance on how to best diagnose and optimize the treatment of ADHD in the pediatric population.

8:00 am - 9:00 am

Industry Symposium†: Clinical Perspectives on a Treatment Option for Bipolar Depression (Bipolar I and II)

David J. Scheiderer, MD, MBA, DFAPA

Sponsored by Intra-Cellular Therapies, Inc.

9:00 am – 9:05 am


9:05 am – 9:35 am

Poster Session†: Clinical Practice Guidelines for Deprescribing or Switching Hypnotic Medications for Insomnia: Guidance from the Alliance for Sleep

Christopher Lettieri, MD, FCCP, FAASM

Sponsored by Idorsia Pharmaceuticals

9:35 am - 10:35 am

Now That I’m Older: Managing Adult ADHD

David W. Goodman, MD, FAPA

Unfortunately, ADHD is not a disorder only of childhood -it often persists into adulthood. Here, Dr. David Goodman will impart best strategies for recognizing ADHD and discuss treatment options available that may best suit the individual needs of the adult patient with ADHD.

10:35 am - 11:00 am

Live Panel Q&A

David Goodman, MD, FAPA and Adelaide S. Robb, MD

†The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. These events are not part of the scientific program and do not provide CME/CE credit. By opening a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.

Program Faculty

David W. Goodman, MD, FAPA

Assistant Professor, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD

Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, State University of New York Upstate, Syracuse, NY

David W. Goodman, MD, FAPA, is an assistant professor in the department of psychiatry and behavioral sciences at Johns Hopkins School of Medicine in Baltimore, and the director and founder of the Adult Attention Deficit Disorder Center of Maryland in Baltimore, MD. His interests include adult ADHD, associated mood/anxiety/substance use disorders, and complex psychopharmacology. 

read more +

Adelaide S. Robb, MD

Distinguished Endowed Professor and Chair, Division of Psychiatry and Behavioral Sciences, Children’s National Hospital, The George Washington University School of Medicine and Health Sciences, Washington, DC

Chair, Data and Safety Monitoring Board (DSMB), National Institute of Mental Health

Member, DSMB; Otsuka America Pharmaceutical, Syneos Health, Tetra Therapeutics

Adelaide S. Robb, MD, is a psychopharmacologist with ongoing research studies in depression and mood disorders, anxiety, and attention deficit disorder. She is Chief of the Division of Psychiatry and Behavioral Sciences.

Dr. Robb, who trained at Johns Hopkins University and the National Institutes of Health, has been on the medical staff in the Division of Psychiatry and Behavioral Medicine since 1996, rising to the rank of Professor (with tenure). She is an internationally known clinical researcher and has participated in and led multiple therapeutic trials for children with a variety of behavioral and psychiatric conditions.  

Dr. Robb is currently a tenured Professor of Psychiatry and of Pediatrics at George Washington University School of Medicine and Health Sciences and Director of Psychiatry Research at the Center for Translation Science within Children’s National. Dr. Robb’s research focus is in psychopharmacology.

read more +